CD8A and neoplasm: As shown in Figure 7D, 7E, we observed a significant increase in the ratio of ICT-treated tumor-infiltrating CD8+ T cells to FoxP3+ regulatory T-cells compared to the control group, indicating that ICT activated the antitumor response of cytotoxic T lymphocytes.